Pharmacovigilance and Pharmacoepidemiology (ISSN: 2638-8235)

Abstract

Introduction The absence of the centralized system of the pharmaceutical product’s authorization in Europe or USA has led to several tragedies: sulfanilamide elixir, thalidomide tragedy and etc. [1]. This example shows that regulators should take into consideration not only the properties of the known API but also the safety of the excipient View more

Abstract

Human deaths due to cancer have risen sharply, in recent years. Cancer is one of the most important causes of morbidity and mortality, worldwide, with nearly 14 million new cases in 2012 [1]. It, also, remains the second leading cause of death in the world and is responsible for 8.8 million deaths in 2015 [2]. In Greece, cancer is the second l View more

Abstract

Risk-benefit analysis is a core professional responsibility of physicians. It assumes particular importance when prescribing drugs such as antipsychotics with a potentially lethal side effect, namely Sudden Cardiac Death (SCD) from Torsades de Pointes (TdP). However, it is also an imperative to place this risk in perspective when treating pati View more

Abstract

Corresponding authorClement Boateng Ampadu, Department of Biostatistics, USA, Tel: +1-6174697268, E-mail: drampadu@hotmail.comCitationAmpadu BC. Gull alpha power of the chen type (2020) Pharmacovigil and Pharmacoepi 3: 16-17. View more